Publications by authors named "Evelyne Pierron"
In March 2020, World Health Organization recognized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence as a public health emergency of international concern. One of the major preventative measures developed against coronavirus disease 2019 (COVID-19) was vaccines. To monitor their use and safety of vaccines from the first utilization in humans during clinical development phases to implementation for the general population, an enhanced national pharmacovigilance system was enabled by the French National Agency for Medicines and Health Products Safety in collaboration with the 30 Regional Pharmacovigilance Centres.
View Article and Find Full Text PDFArticle Synopsis
- In 2018, the "Ateliers de Giens" focused on the potential benefits of AI in clinical research and pharmacovigilance, leading to increased efficiency in healthcare.
- The 2022 workshop aimed to enhance the role of AI and intelligent automation in pharmacovigilance, addressing the challenges posed by increased reporting of suspected side effects and a lack of medical expertise.
- Participants discussed their experiences and projects, created a SWOT analysis to identify critical issues, and proposed recommendations for integrating new technologies while preserving expertise in pharmacovigilance.